Login to Your Account

Golden ear-ring: Auris ahead in tinnitus race, Otonomy eyes efforts

By Randy Osborne
Staff Writer

Thursday, March 12, 2015

Auris Medical Holding AG brought the long-overlooked indication of tinnitus to the fore with word that enrollment will continue in its phase III trial testing AM-101 against the disorder, since the pre-specified futility threshold was not reached.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription